结核专科门诊耐多药结核病患者就诊个案管理方法研究
摘要
关键词
全文:
PDF参考
[1]吴世东, 窦飞, 谭涌泉.耐多药肺结核患者不同化疗方案的临床疗效及不良反应对比[J].临床医学工程,2016.23(3):347-348 [2] Oga-Omenka C,Tseja-Akinrin A,Sen P. Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin -resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review. BMJ Glob Health. 2020 Jul;5(7):e002280. [3] Kang Y, Jo EJ, Eom JS. Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Comparison of Pre- and Post-Public-Private Mix Periods. Tuberc Respir Dis (Seoul). 2021 Jan;84(1):74-83. [4] Edwards BD, Edwards J, Cooper R. Rifampin-resistant/ multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting. PLoS One. 2021 Feb 16;16(2):e0246993.
DOI: http://dx.doi.org/10.12361/2661-3603-04-03-79818
Refbacks
- 当前没有refback。